They demonstrated a uniform loss of SMARCB1 protein in malignant rhabdoid tumors (MRTs), characterized by the classic pattern of germline loss of one allele followed by the somatic loss of the second allele. The gene discussed is SMARCB1; the disease is rhabdoid tumor.